Caris Life Sciences, Inc. (CAI): Total Assets
$1.13B
As of 2025-12-31
$1.23B
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.13B | +227.5% | 2026-03-03, Balance as of period end |
| 2024-12-31 | $343.73M | n/a | 2026-03-03, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $3.76B | +14.4% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Natera, Inc. (NTRA) | 2025-12-31 | $2.40B | +44.4% |
Compare CAI, GH, VCYT, CDNA side by side · Screen every company in Services-Medical Laboratories ↗